CNR Institutional Research Information System

DE FALCO, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 783
NA - Nord America 516
EU - Europa 180
SA - Sud America 147
AF - Africa 17
OC - Oceania 1
Totale 1.644
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 489
SG - Singapore 342
CN - Cina 174
BR - Brasile 117
VN - Vietnam 87
HK - Hong Kong 83
IT - Italia 45
FR - Francia 41
JP - Giappone 25
NL - Olanda 20
KR - Corea 16
AR - Argentina 15
DE - Germania 13
MX - Messico 13
GB - Regno Unito 12
FI - Finlandia 11
IN - India 9
BD - Bangladesh 8
CA - Canada 7
ID - Indonesia 7
UA - Ucraina 7
EC - Ecuador 6
IQ - Iraq 6
ZA - Sudafrica 6
AT - Austria 5
SE - Svezia 5
IE - Irlanda 4
TR - Turchia 4
CO - Colombia 3
DZ - Algeria 3
ES - Italia 3
HN - Honduras 3
IL - Israele 3
NG - Nigeria 3
RU - Federazione Russa 3
BG - Bulgaria 2
CR - Costa Rica 2
CY - Cipro 2
EE - Estonia 2
HU - Ungheria 2
PK - Pakistan 2
PY - Paraguay 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
CH - Svizzera 1
CL - Cile 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
JO - Giordania 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 1.644
Salva come PNG Salva come JPEG
Città #
Santa Clara 201
Singapore 180
Hong Kong 82
Beijing 56
Hefei 40
Lauterbourg 36
San Jose 34
Ho Chi Minh City 33
Los Angeles 31
Ashburn 26
Tokyo 20
Hanoi 19
Seoul 16
Helsinki 10
Marigliano 10
São Paulo 10
New York 9
Buffalo 7
Johannesburg 6
Brooklyn 5
London 5
Stockholm 5
Washington 5
Avellino 4
Baghdad 4
Curitiba 4
Denver 4
Florence 4
Haiphong 4
Lecce 4
Naples 4
Nuremberg 4
Orem 4
The Bronx 4
Chennai 3
Dallas 3
Dhaka 3
Falkenstein 3
Mexico City 3
Querétaro 3
Rio de Janeiro 3
Rome 3
San Francisco 3
Seattle 3
Vienna 3
Acalanes Ridge 2
Amsterdam 2
Araranguá 2
Bariri 2
Bengaluru 2
Brescia 2
Buenos Aires 2
Campinas 2
Dublin 2
Eagleville 2
Goiânia 2
Guayaquil 2
Houston 2
Lagos 2
Las Vegas 2
Lomas de Zamora 2
Manchester 2
Marília 2
Miami 2
Milan 2
Milwaukee 2
Minamishinagawa 2
Montreal 2
Nicosia 2
Ninh Bình 2
Niterói 2
Osaka 2
Osasco 2
Phoenix 2
Phủ Lý 2
Piscataway 2
Queens 2
Quảng Ninh 2
Salvador 2
San José 2
Serrinha 2
Shanghai 2
Shenzhen 2
Spotorno 2
Tashkent 2
The Dalles 2
Uberlândia 2
Vinh 2
Abuja 1
Addis Ababa 1
Ahmedabad 1
Albuquerque 1
Alfenas 1
Algiers 1
Alvorada 1
Amman 1
Ankara 1
Antakya 1
Anápolis 1
Araçatuba 1
Totale 1.021
Salva come PNG Salva come JPEG
Nome #
The b-catenin Axis Integrates Multiple Signals Downstream From RET/PTC and Leads to Cell Proliferation. 69
N-Acetyl-L-Cysteine (NAC) Blunts Axitinib-Related Adverse Effects in Preclinical Models of Glioblastoma 63
Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics 60
A new germline RET mutation apparently devoid of transforming activity serendipitously discovered in a patient with atrophic autoimmune thyroiditis and primary ovarian failure 59
Targeted Cancer Therapy and Mechanisms of Resistance 56
The Role of Nutrients in Prevention, Treatment and Post-Coronavirus Disease-2019 (COVID-19) 55
The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells 55
Targeting the p90RSK/MDM2/p53 Pathway Is Effective in Blocking Tumors with Oncogenic Up-Regulation of the MAPK Pathway Such as Melanoma and Lung Cancer 53
Next-generation sequencing analysis of receptor-type tyrosine kinase genes in surgically resected colon cancer: Identification of gain-of-function mutations in the RET proto-oncogene 52
Ponatinib (AP24534) is a novel potent inhibitor of oncogenic RET mutants associated with thyroid cancer. 52
Effects of combined administration of rapamycin, tolvaptan and AEZ-131 on progression of polycystic disease in PCK rats. 49
CD44 proteolysis increases CREB phosphorylation and sustains proliferation of thyroid cancer cells. 49
p90RSK Regulates p53 Pathway by MDM2 Phosphorylation in Thyroid Tumors 48
A novel pathway of cell growth regulation mediated by a PLA2alpha-derived phosphoinositide metabolite 46
Fragment-Based Discovery of a Dual pan-RET/VEGFR2 Kinase Inhibitor Optimized for Single-Agent Polypharmacology 46
The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer 45
Calcium/calmodulin-dependent protein kinase II and its endogenous inhibitor ? in medullary thyroid cancer. 45
Osteopontin is overexpressed in human papillary thyroid carcinomas and enhances thyroid carcinoma cell invasiveness. 44
Cytosolic phospholipase A2 alpha regulates cell growth in RET/PTC-transformed thyroid cells 43
XB130 mediates cancer cell proliferation and survival through multiple signaling events downstream of Akt. 42
Calcium/calmodulin-dependent protein kinase II and ITS endogenous inhibitor a in medullary thyroid cancer 41
The tyrosine kinase inhibitor ZD6474 blocks proliferation of RET mutant medullary thyroid carcinoma cells. 39
XB130, a tissue-specific adaptor protein that couples the RET/PTC oncogenic kinase to PI 3-kinase pathway. 39
BRAF is a therapeutic target in aggressive thyroid carcinoma. 38
Glioblastoma: Overview of Proteomic Investigations and Biobank Approaches for the Development of a Multidisciplinary Translational Network 37
RET/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase. 36
The Ca2+-calmodulin-dependent kinase II is activated in papillary thyroid carcinoma (PTC) and mediates cell proliferation stimulated by RET/PTC 36
Targeting RET Kinase in Thyroid Cancer 36
Cytostatic activity of adenosine triphosphate-competitive kinase inhibitors in BRAF mutant thyroid carcinoma cells 36
Mitochondrial Localization and Regulation of BRAF(V600E) in Thyroid Cancer: A Clinically Used RAF Inhibitor Is Unable to Block the Mitochondrial Activities of BRAF(V600E) 34
The β-Catenin axis integrates multiple signals downstream from RET/Papillary thyroid carcinoma leading to cell proliferation 34
Biochemical and molecular characterization of the novel BRAF V599Ins mutation detected in a classic papillary thyroid carcinoma 32
The RET/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells 30
The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma. 28
Ras-mediated apoptosis of PC CL 3 rat thyroid cells induced by RET/PTC oncogenes 27
RAI(ShcC/N-Shc)-dependent recruitment of GAB 1 to RET oncoproteins potentiates PI 3-K signalling in thyroid tumors. 27
Functional characterization of the novel T599I-VKSRdel BRAF mutation in a follicular variant papillary thyroid carcinoma 25
Molecular genetics of medullary thyroid carcinoma: The quest for novel therapeutic targets 25
Functional expression of the CXCR4 chemokine receptor is induced by RET/PTC oncogenes and is a common event in human papillary thyroid carcinomas 24
Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer 23
Insights into the molecular function of the inactivating mutations of B-Raf involving the DFG motif 23
The beta-catenin axis integrates multiple signals downstream from RET/papillary thyroid carcinoma leading to cell proliferation. 18
Totale 1.719
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.388
article - articoli 5.388
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.776
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202411 0 0 0 0 0 0 0 0 2 0 9 0
2024/2025757 8 1 48 20 216 41 10 69 62 27 135 120
2025/2026951 31 86 75 151 188 72 144 38 60 80 26 0
Totale 1.719